Provided by Tiger Trade Technology Pte. Ltd.

Recursion Pharmaceuticals, Inc.

3.50
+0.16004.79%
Post-market: 3.500.00000.00%19:59 EDT
Volume:22.90M
Turnover:80.71M
Market Cap:1.87B
PE:-3.42
High:3.63
Open:3.39
Low:3.37
Close:3.34
52wk High:7.18
52wk Low:2.77
Shares:535.00M
Float Shares:522.33M
Volume Ratio:1.28
T/O Rate:4.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0219
EPS(LYR):-1.4410
ROE:-56.58%
ROA:-27.33%
PB:2.05
PE(LYR):-2.43

Loading ...

Oct 29, 2025

Major Issues Report

Form 8-K - Current report
Oct 23, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer Gibson proposes to sell 100,000 shares, with a total value of approximately $570,000.
Oct 10, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer Christopher Gibson proposes to sell 100,000 Shares, with a total value of approximately $604,000.
Sep 25, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals Officer Gibson proposes to sell 100,000 shares, with a total value of approximately $476,000.
Sep 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 29, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
Aug 26, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals's Officer Christopher Gibson proposes to sell 100,000 Shares, with a total value of approximately $484,000.
Aug 18, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals Officer Khan Najat proposes to sell 36,599 shares, with a total value of approximately $202,169.22.
Aug 11, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer Christopher Gibson proposes to sell 617,875 Shares, with a total value of approximately $3.26 Million.
Aug 05, 2025

Major Issues Report

Form 8-K - Current report
Aug 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 08, 2025

Major Issues Report

Form 8-K - Current report
Jun 18, 2025

Major Issues Report

Form 8-K - Current report
Jun 10, 2025

Major Issues Report

Form 8-K - Current report
May 09, 2025

Major Issues Report

Form 8-K - Current report
May 05, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2025

Major Issues Report

Form 8-K - Current report
Mar 27, 2025

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals Officer Gibson Christopher proposes to sell 138,574 Shares, with a total value of approximately $836,987.
Mar 18, 2025

Major Issues Report

Form 8-K - Current report